May 15 (Reuters)-
Daiken Medical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2019 Mar 31, 2018 Mar 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 8.41 8.59 8.50 4.15
(-2.1 pct) (+2.2 pct) (+1.1 pct) (-1.1 pct)
Operating 1.25 1.51 1.28 580 mln
(-17.0 pct) (-12.0 pct) (+2.4 pct) (-17.8 pct)
Recurring 1.25 1.50 1.30 600 mln
(-17.2 pct) (-12.3 pct) (+4.3 pct) (-14.7 pct)
Net 851 mln 1.01 870 mln 400 mln
(-15.9 pct) (-18.8 pct) (+2.2 pct) (-17.6 pct)
EPS 29.05 yen 33.79 yen 30.28 yen 13.92 yen
EPS Diluted 33.76 yen
Ann Div 20.00 yen 25.00 yen 20.00 yen
-Q2 Div 10.00 yen 9.00 yen 9.00 yen
-Q4 Div 10.00 yen 16.00 yen 11.00 yen
NOTE - Daiken Medical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7775.T